talent15-stocks-header-logotalent15-stocks-header-logotalent15-stocks-header-logotalent15-stocks-header-logo
  • Stock Trading for the Rest of Us
  • About us
  • Forum
    • Log In
    • Register
  • Contact
  • Start Trading
Cerecor, Inc. (CERC)
June 25, 2021
Hello world!
August 2, 2021
Published by admin on July 27, 2021
Categories
  • Wins
Tags

On 5/18 we alerted Kintara Therapeutics, Inc. (KTRA) at $1.28 entry. Peaked 6 weeks at $2.85 for a 122% gain. 

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California.

Share
0
admin
admin

Related posts

June 25, 2021

Cerecor, Inc. (CERC)


Read more
February 10, 2021

Ocugen, Inc. (OCGN)


Read more

Leave a Reply Cancel reply

You must be logged in to post a comment.

talent15-stocks-header-logo

Follow us

Connect with us


P.O. Box 121
Kannapolis, NC 28082
United States
info@talentfifteen.com
+1.980.296.1515

Recent Posts

  • Kintara Therapeutics, Inc. (KTRA)
  • Cerecor, Inc. (CERC)
  • Ocugen, Inc. (OCGN)
© 2021 Talent Fifteen | All Rights Reserved